Skip to content

03.2 / Industries / DDS

Drug delivery

Metered release from patches, microneedle arrays and depots, with the dose rate set by design rather than a motor.

The problem

Controlled release usually means a choice between a membrane that diffuses at whatever rate the chemistry allows and an active pump that adds a battery, electronics and a failure mode.

What we do

Gradient-coated channels move formulation at a rate fixed by the surface design. We help you set that rate, prove it on prototypes, and carry the design into a process your contract manufacturer can run.

Device types

  • DDS-01

    Transdermal patches

    Channel arrays that move drug to the skin surface

  • DDS-02

    Microneedle arrays

    Feeding formulation to the needle field

  • DDS-03

    Implantable depots

    Long-duration release with no moving parts

  • DDS-04

    Ocular delivery

    Small-volume metering in tight geometries

  • DDS-05

    Inhalation devices

    Liquid management ahead of aerosolization

  • DDS-06

    Combination therapy

    Two drugs, two rates, one device

Design constraints we plan for

  • Viscous formulations
  • Biocompatible substrates
  • Shelf-life stability